Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dotinurad vs Allopurinol in Tophaceous Gout
NCT07089888Phase 3Recruiting
- Sponsor
- Crystalys Therapeutics
- Start
- Aug 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dotinurad in gout, sponsored by Crystalys Therapeutics. Started Aug 2025; status: recruiting.
02
Drugs
dotinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT07089888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07089888.